Literature DB >> 3994900

A comparison of standard and sustained release clonidine with respect to plasma concentration and blood pressure changes.

J L Shaffer, B J Pleuvry, D S Davies, S Murray.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3994900      PMCID： PMC1463808          DOI： 10.1111/j.1365-2125.1985.tb02681.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  5 in total

1.  Pharmacokinetics and concentration-effect relationships of intervenous and oral clonidine.

Authors:  D S Davies; A M Wing; J L Reid; D M Neill; P Tippett; C T Dollery
Journal:  Clin Pharmacol Ther       Date:  1977-05       Impact factor: 6.875

2.  Menopausal flushing: double-blind trial of a non-hormonal medication.

Authors:  J R Clayden; J W Bell; P Pollard
Journal:  Br Med J       Date:  1974-03-09

3.  Evaluation of clonidine in prophylaxis of migraine. Double-blind trial and follow-up.

Authors:  J Shafar; E R Tallett; P A Knowlson
Journal:  Lancet       Date:  1972-02-19       Impact factor: 79.321

4.  2-(2.6-dichlorophenylamino)-2-imidazoline hydrochloride (ST 155 or Catapresan) as a prophylactic remedy against migraine.

Authors:  O Sjaastad; P Stensrud
Journal:  Acta Neurol Scand       Date:  1971       Impact factor: 3.209

5.  Bis(trifluoromethyl)aryl derivatives for drug analysis by gas chromatography electron capture negative ion chemical ionization mass spectrometry. Application to the measurement of low levels of clonidine in plasma.

Authors:  S Murray; D S Davies
Journal:  Biomed Mass Spectrom       Date:  1984-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.